BioSpace News Archive

Anti-FcRn antibody has potential to become portfolio-in-a-product; ITP trial is the first of several to study safety and efficacy in autoimmune disorders

Crinetics Pharmaceuticals, Inc., a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors, announced the pricing of an underwritten public offering of 7,150,000 shares of its common stock at a price to the public of $14.00 per share.

Coherus BioSciences, Inc., announced the pricing of its offering of $200,000,000 aggregate principal amount of 1.500% convertible senior subordinated notes due 2026 in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended.

The global market for hydrogen breath test analyzer is expected to witness remarkable progress in the near future.

The demand within the global pressure infusion bags market is growing on account of the need for improving emergency units in hospitals.

According to the report, the global angioplasty balloons & stents market was valued at US$ 5.9 Bn in 2018 and is projected to expand at a CAGR of 4.5% from 2019 to 2027.

According to the report, the global nephropathic cystinosis treatment market was valued at ~US$ 215 Mn in 2018.

PIC Therapeutics, a biotechnology company focused on transforming the treatment of cancer though the selective modulation of oncogene translation, closed a $5M Series Seed round of preferred equity funding.

UnitedHealth Group announced that Sir Andrew Witty, president of UnitedHealth Group and CEO of Optum, has been asked to co-lead a global effort of the World Health Organization, in partnership with key stakeholders, to accelerate the development of a COVID-19 vaccine.

A non-profit initiative providing a WHO-approved solution to get tested and diagnosed for COVID-19 from home in Hong Kong